Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.breast.2011.01.015
DC FieldValue
dc.titleBreast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based breast cancer registry
dc.contributor.authorBhoo Pathy, N.
dc.contributor.authorYip, C.H.
dc.contributor.authorTaib, N.A.
dc.contributor.authorHartman, M.
dc.contributor.authorSaxena, N.
dc.contributor.authorIau, P.
dc.contributor.authorBulgiba, A.M.
dc.contributor.authorLee, S.C.
dc.contributor.authorLim, S.E.
dc.contributor.authorWong, J.E.L.
dc.contributor.authorVerkooijen, H.M.
dc.date.accessioned2014-11-26T07:43:14Z
dc.date.available2014-11-26T07:43:14Z
dc.date.issued2011-04
dc.identifier.citationBhoo Pathy, N., Yip, C.H., Taib, N.A., Hartman, M., Saxena, N., Iau, P., Bulgiba, A.M., Lee, S.C., Lim, S.E., Wong, J.E.L., Verkooijen, H.M. (2011-04). Breast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based breast cancer registry. Breast 20 (SUPPL. 2) : S75-S80. ScholarBank@NUS Repository. https://doi.org/10.1016/j.breast.2011.01.015
dc.identifier.issn09609776
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/109218
dc.description.abstractTwo hospital-based breast cancer databases (University Malaya Medical Center, Malaysia [. n = 1513] and National University Hospital, Singapore [. n = 2545]) were merged into a regional registry of breast cancer patients diagnosed between 1990 and 2007. A review of the data found 51% of patients diagnosed before the age of 50 years. and 72% percent of the women were Chinese followed by Malays (16%), Indians (8%), and other races (4%). Median tumor size at presentation was 26 mm and about 25% of patients presented with TNM stage III or IV disease. Most tumors were of ductal histology (87%). Fifty-seven percent of tumors were estrogen receptor positive and 40% were poorly differentiated. Of those patients who had surgery, 70% had mastectomy while 30% had breast conserving surgery. Overall, chemotherapy was administered to 56% of patients and hormonal treatment to 60%. Five-year overall survival was 82.5% in patients with TNM stage 0 to stage II cancer, and 30.2% in those with later stages. © 2011 Elsevier Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.breast.2011.01.015
dc.sourceScopus
dc.subjectAsia
dc.subjectAsian
dc.subjectBreast cancer
dc.subjectCancer registry
dc.typeArticle
dc.contributor.departmentEPIDEMIOLOGY & PUBLIC HEALTH
dc.description.doi10.1016/j.breast.2011.01.015
dc.description.sourcetitleBreast
dc.description.volume20
dc.description.issueSUPPL. 2
dc.description.pageS75-S80
dc.description.codenBREAE
dc.identifier.isiut000290194000014
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.